vi atcc atcc33458 wild type strain Search Results


vi atcc atcc33458 wild type strain  (ATCC)
94
ATCC vi atcc atcc33458 wild type strain
Vi Atcc Atcc33458 Wild Type Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vi atcc atcc33458 wild type strain/product/ATCC
Average 94 stars, based on 1 article reviews
vi atcc atcc33458 wild type strain - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
salmonella enterica  (ATCC)
98
ATCC salmonella enterica
Zones of inhibition (mm) of raw and fermented extracts against indicator organisms at 50 mg/mL.
Salmonella Enterica, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/salmonella enterica/product/ATCC
Average 98 stars, based on 1 article reviews
salmonella enterica - by Bioz Stars, 2026-02
98/100 stars
  Buy from Supplier
salmonella typhi  (ATCC)
93
ATCC salmonella typhi
Zones of inhibition (mm) of raw and fermented extracts against indicator organisms at 50 mg/mL.
Salmonella Typhi, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/salmonella typhi/product/ATCC
Average 93 stars, based on 1 article reviews
salmonella typhi - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
wild type escherichia coli  (ATCC)
94
ATCC wild type escherichia coli
Uptake of [ 18 F]MFTMT. (a) Uptake of [ 18 F]-MFTMT by bacteria and CHO-K1 cells. Bacteria, E. coli , S. aureus , and LamB mutant E. coli (LamB KO E. coli ), and CHO-K1 cells were incubated with [ 18 F]MFTMT at concentrations of 5, 10, 15, and 20 μCi mL −1 for 1 h. S. aureus internalized [ 18 F]MFTMT, while E. coli , LamB KO E. coli , and CHO-K1 cells did not internalize [ 18 F]MFTMT. (b) Uptake of [ 18 F]MFTMT by common pathogens for implantable medical device infection, Staphylococcus epidermidis ( S. epidermidis ), Pseudomonas aeruginosa ( P. aeruginosa ), Enterococcus faecalis ( E. faecalis ) and Streptococcus sanguinis ( S. sanguinis ), were evaluated. Bacteria were incubated with 20 μCi mL −1 of [ 18 F]MFTMT for 1 h, and the remaining radioactivity was evaluated. Only S. aureus internalized significant radioactivity, on the other hand, other bacteria internalized minimal radioactivity.
Wild Type Escherichia Coli, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wild type escherichia coli/product/ATCC
Average 94 stars, based on 1 article reviews
wild type escherichia coli - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

Image Search Results


Zones of inhibition (mm) of raw and fermented extracts against indicator organisms at 50 mg/mL.

Journal: International Journal of Microbiology

Article Title: In Vitro Evaluation of Antimicrobial Efficacy of Extracts Obtained from Raw and Fermented Wild Macrofungus, Lenzites quercina

doi: 10.1155/2015/106308

Figure Lengend Snippet: Zones of inhibition (mm) of raw and fermented extracts against indicator organisms at 50 mg/mL.

Article Snippet: Microbial strains, Staphylococcus aureus (ATCC 29213), Escherichia coli (ATCC 35218), Pseudomonas aeruginosa (ATCC 27853), Shigella flexneri (ATCC12022), Salmonella enterica (ATCC 33458), Bacillus subtilis (ATCC 6633), and Enterobacter aerogenes (ATCC 13048), Shigella flexneri , Salmonella typhi , Pseudomonas aeruginosa , Bacillus cereus , Enterococcus faecalis , Escherichia coli , Staphylococcus aureus , Methicillin Resistant Staphylococcus aureus (MRSA), Candida albicans , Aspergillus niger, and Aspergillus flavus, were collected from Medical Microbiology Laboratory, University College Hospital (UCH), Ibadan, Oyo State, and Ondo State Specialist Hospital, Akure, Ondo State.

Techniques: Inhibition

Zones of inhibition of purified fractions against tested organisms at 2.0 mg/mL.

Journal: International Journal of Microbiology

Article Title: In Vitro Evaluation of Antimicrobial Efficacy of Extracts Obtained from Raw and Fermented Wild Macrofungus, Lenzites quercina

doi: 10.1155/2015/106308

Figure Lengend Snippet: Zones of inhibition of purified fractions against tested organisms at 2.0 mg/mL.

Article Snippet: Microbial strains, Staphylococcus aureus (ATCC 29213), Escherichia coli (ATCC 35218), Pseudomonas aeruginosa (ATCC 27853), Shigella flexneri (ATCC12022), Salmonella enterica (ATCC 33458), Bacillus subtilis (ATCC 6633), and Enterobacter aerogenes (ATCC 13048), Shigella flexneri , Salmonella typhi , Pseudomonas aeruginosa , Bacillus cereus , Enterococcus faecalis , Escherichia coli , Staphylococcus aureus , Methicillin Resistant Staphylococcus aureus (MRSA), Candida albicans , Aspergillus niger, and Aspergillus flavus, were collected from Medical Microbiology Laboratory, University College Hospital (UCH), Ibadan, Oyo State, and Ondo State Specialist Hospital, Akure, Ondo State.

Techniques: Inhibition, Purification

Minimum inhibitory concentration (MIC) of Lenzites quercina extracts (mg/mL) against tested organisms.

Journal: International Journal of Microbiology

Article Title: In Vitro Evaluation of Antimicrobial Efficacy of Extracts Obtained from Raw and Fermented Wild Macrofungus, Lenzites quercina

doi: 10.1155/2015/106308

Figure Lengend Snippet: Minimum inhibitory concentration (MIC) of Lenzites quercina extracts (mg/mL) against tested organisms.

Article Snippet: Microbial strains, Staphylococcus aureus (ATCC 29213), Escherichia coli (ATCC 35218), Pseudomonas aeruginosa (ATCC 27853), Shigella flexneri (ATCC12022), Salmonella enterica (ATCC 33458), Bacillus subtilis (ATCC 6633), and Enterobacter aerogenes (ATCC 13048), Shigella flexneri , Salmonella typhi , Pseudomonas aeruginosa , Bacillus cereus , Enterococcus faecalis , Escherichia coli , Staphylococcus aureus , Methicillin Resistant Staphylococcus aureus (MRSA), Candida albicans , Aspergillus niger, and Aspergillus flavus, were collected from Medical Microbiology Laboratory, University College Hospital (UCH), Ibadan, Oyo State, and Ondo State Specialist Hospital, Akure, Ondo State.

Techniques: Concentration Assay

Minimum bactericidal concentration (MBC) of Lenzites quercina extracts (mg/mL) against tested organisms.

Journal: International Journal of Microbiology

Article Title: In Vitro Evaluation of Antimicrobial Efficacy of Extracts Obtained from Raw and Fermented Wild Macrofungus, Lenzites quercina

doi: 10.1155/2015/106308

Figure Lengend Snippet: Minimum bactericidal concentration (MBC) of Lenzites quercina extracts (mg/mL) against tested organisms.

Article Snippet: Microbial strains, Staphylococcus aureus (ATCC 29213), Escherichia coli (ATCC 35218), Pseudomonas aeruginosa (ATCC 27853), Shigella flexneri (ATCC12022), Salmonella enterica (ATCC 33458), Bacillus subtilis (ATCC 6633), and Enterobacter aerogenes (ATCC 13048), Shigella flexneri , Salmonella typhi , Pseudomonas aeruginosa , Bacillus cereus , Enterococcus faecalis , Escherichia coli , Staphylococcus aureus , Methicillin Resistant Staphylococcus aureus (MRSA), Candida albicans , Aspergillus niger, and Aspergillus flavus, were collected from Medical Microbiology Laboratory, University College Hospital (UCH), Ibadan, Oyo State, and Ondo State Specialist Hospital, Akure, Ondo State.

Techniques: Concentration Assay

Uptake of [ 18 F]MFTMT. (a) Uptake of [ 18 F]-MFTMT by bacteria and CHO-K1 cells. Bacteria, E. coli , S. aureus , and LamB mutant E. coli (LamB KO E. coli ), and CHO-K1 cells were incubated with [ 18 F]MFTMT at concentrations of 5, 10, 15, and 20 μCi mL −1 for 1 h. S. aureus internalized [ 18 F]MFTMT, while E. coli , LamB KO E. coli , and CHO-K1 cells did not internalize [ 18 F]MFTMT. (b) Uptake of [ 18 F]MFTMT by common pathogens for implantable medical device infection, Staphylococcus epidermidis ( S. epidermidis ), Pseudomonas aeruginosa ( P. aeruginosa ), Enterococcus faecalis ( E. faecalis ) and Streptococcus sanguinis ( S. sanguinis ), were evaluated. Bacteria were incubated with 20 μCi mL −1 of [ 18 F]MFTMT for 1 h, and the remaining radioactivity was evaluated. Only S. aureus internalized significant radioactivity, on the other hand, other bacteria internalized minimal radioactivity.

Journal: RSC Advances

Article Title: Synthesis, radiolabeling, and biological evaluation of methyl 6-deoxy-6-[ 18 F]fluoro-4-thio-α- d -maltotrioside as a positron emission tomography bacterial imaging agent †

doi: 10.1039/d5ra00693g

Figure Lengend Snippet: Uptake of [ 18 F]MFTMT. (a) Uptake of [ 18 F]-MFTMT by bacteria and CHO-K1 cells. Bacteria, E. coli , S. aureus , and LamB mutant E. coli (LamB KO E. coli ), and CHO-K1 cells were incubated with [ 18 F]MFTMT at concentrations of 5, 10, 15, and 20 μCi mL −1 for 1 h. S. aureus internalized [ 18 F]MFTMT, while E. coli , LamB KO E. coli , and CHO-K1 cells did not internalize [ 18 F]MFTMT. (b) Uptake of [ 18 F]MFTMT by common pathogens for implantable medical device infection, Staphylococcus epidermidis ( S. epidermidis ), Pseudomonas aeruginosa ( P. aeruginosa ), Enterococcus faecalis ( E. faecalis ) and Streptococcus sanguinis ( S. sanguinis ), were evaluated. Bacteria were incubated with 20 μCi mL −1 of [ 18 F]MFTMT for 1 h, and the remaining radioactivity was evaluated. Only S. aureus internalized significant radioactivity, on the other hand, other bacteria internalized minimal radioactivity.

Article Snippet: To evaluate the uptake of [ 18 F]MFTMT by bacteria and mammalian cells, we used wild-type Escherichia coli ( E. coli , ATCC33456), wild-type Staphylococcus aureus ( S. aureus , ATCC25923), LamB mutant E. coli (LamB KO E. coli , JW3996-1), Staphylococcus epidermidis (NRS101), Pseudomonas aeruginosa (ATCC 27853), Enterococcus faecalis (ATCC 29212), Streptococcus sanguinis (ATCC 10556) and CHO-K1 cells (ATCC CCL61).

Techniques: Bacteria, Mutagenesis, Incubation, Infection, Radioactivity

[ 18 F]MFTMT PET imaging of device infection model in rats. (a) [ 18 F]MFTMT PET imaging was conducted on a skin-pocket-infection model in rats, utilizing sum images from 30 to 60 min for evaluation. The location of the mock-up was confirmed by merging images of PET and CT. Coronal and sagittal sections of PET images are shown in the ESI Fig. S12. No radioactivity accumulation was observed in the mock-up area in the control rats. Radioactivity accumulated not only in the mock-up area in S. aureus -infected rats but also in E. coli -infected rats and rats with non-infectious inflammation. Arrows show mock-up areas. (b) Radioactivity accumulation around the mock-up area and normal skin was compared using the ratio of SUV in the mock-up area and normal skin area. The mean SUV ratio in the mock-up area was significantly increased in S. aureus -infected rats, E. coli -infected rats, and non-infectious inflammation rats compared to control rats. SUV max ratio was increased in S. aureus -infected rats. SUVs in the normal skin area were similar across the four groups. The remaining radioactivity in the blood was evaluated by placing the ROI on the left ventricle, indicated as a ratio to the injected radioactivity (% ID per g tissue). * Indicates p < 0.05.

Journal: RSC Advances

Article Title: Synthesis, radiolabeling, and biological evaluation of methyl 6-deoxy-6-[ 18 F]fluoro-4-thio-α- d -maltotrioside as a positron emission tomography bacterial imaging agent †

doi: 10.1039/d5ra00693g

Figure Lengend Snippet: [ 18 F]MFTMT PET imaging of device infection model in rats. (a) [ 18 F]MFTMT PET imaging was conducted on a skin-pocket-infection model in rats, utilizing sum images from 30 to 60 min for evaluation. The location of the mock-up was confirmed by merging images of PET and CT. Coronal and sagittal sections of PET images are shown in the ESI Fig. S12. No radioactivity accumulation was observed in the mock-up area in the control rats. Radioactivity accumulated not only in the mock-up area in S. aureus -infected rats but also in E. coli -infected rats and rats with non-infectious inflammation. Arrows show mock-up areas. (b) Radioactivity accumulation around the mock-up area and normal skin was compared using the ratio of SUV in the mock-up area and normal skin area. The mean SUV ratio in the mock-up area was significantly increased in S. aureus -infected rats, E. coli -infected rats, and non-infectious inflammation rats compared to control rats. SUV max ratio was increased in S. aureus -infected rats. SUVs in the normal skin area were similar across the four groups. The remaining radioactivity in the blood was evaluated by placing the ROI on the left ventricle, indicated as a ratio to the injected radioactivity (% ID per g tissue). * Indicates p < 0.05.

Article Snippet: To evaluate the uptake of [ 18 F]MFTMT by bacteria and mammalian cells, we used wild-type Escherichia coli ( E. coli , ATCC33456), wild-type Staphylococcus aureus ( S. aureus , ATCC25923), LamB mutant E. coli (LamB KO E. coli , JW3996-1), Staphylococcus epidermidis (NRS101), Pseudomonas aeruginosa (ATCC 27853), Enterococcus faecalis (ATCC 29212), Streptococcus sanguinis (ATCC 10556) and CHO-K1 cells (ATCC CCL61).

Techniques: Imaging, Infection, Radioactivity, Control, Injection

Uptake of serum treated [ 18 F]MFTMT and [ 18 F]MFTM. (a) Uptake of serum treated [ 18 F]-MFTMT by bacteria and CHO-K1 cells. Bacteria, E. coli , S. aureus , and LamB mutant E. coli (LamB KO E. coli ), and CHO-K1 cells were incubated with the rat serum-treated [ 18 F]MFTMT at concentrations of 1, 5, 10, and 15 μCi mL −1 for 1 h. Consistent with the uptake study with [ 18 F]MFTMT, only S. aureus internalized serum-treated [ 18 F]MFTMT. (b) Uptake of [ 18 F]MFTM by common pathogens for implantable medical device infection, Staphylococcus epidermidis ( S. epidermidis ), Pseudomonas aeruginosa ( P. aeruginosa ), Enterococcus faecalis ( E. faecalis ) and Streptococcus sanguinis ( S. sanguinis ), were evaluated. Bacteria were incubated with 20 μCi mL −1 of [ 18 F]MFTM 1 h, and the remaining radioactivity was evaluated. Similar to the uptake of [ 18 F]MFTMT, only S. aureus internalized massive radioactivity.

Journal: RSC Advances

Article Title: Synthesis, radiolabeling, and biological evaluation of methyl 6-deoxy-6-[ 18 F]fluoro-4-thio-α- d -maltotrioside as a positron emission tomography bacterial imaging agent †

doi: 10.1039/d5ra00693g

Figure Lengend Snippet: Uptake of serum treated [ 18 F]MFTMT and [ 18 F]MFTM. (a) Uptake of serum treated [ 18 F]-MFTMT by bacteria and CHO-K1 cells. Bacteria, E. coli , S. aureus , and LamB mutant E. coli (LamB KO E. coli ), and CHO-K1 cells were incubated with the rat serum-treated [ 18 F]MFTMT at concentrations of 1, 5, 10, and 15 μCi mL −1 for 1 h. Consistent with the uptake study with [ 18 F]MFTMT, only S. aureus internalized serum-treated [ 18 F]MFTMT. (b) Uptake of [ 18 F]MFTM by common pathogens for implantable medical device infection, Staphylococcus epidermidis ( S. epidermidis ), Pseudomonas aeruginosa ( P. aeruginosa ), Enterococcus faecalis ( E. faecalis ) and Streptococcus sanguinis ( S. sanguinis ), were evaluated. Bacteria were incubated with 20 μCi mL −1 of [ 18 F]MFTM 1 h, and the remaining radioactivity was evaluated. Similar to the uptake of [ 18 F]MFTMT, only S. aureus internalized massive radioactivity.

Article Snippet: To evaluate the uptake of [ 18 F]MFTMT by bacteria and mammalian cells, we used wild-type Escherichia coli ( E. coli , ATCC33456), wild-type Staphylococcus aureus ( S. aureus , ATCC25923), LamB mutant E. coli (LamB KO E. coli , JW3996-1), Staphylococcus epidermidis (NRS101), Pseudomonas aeruginosa (ATCC 27853), Enterococcus faecalis (ATCC 29212), Streptococcus sanguinis (ATCC 10556) and CHO-K1 cells (ATCC CCL61).

Techniques: Bacteria, Mutagenesis, Incubation, Infection, Radioactivity